US firm rakes in $1.1bn ahead of COVID-19 vaccine launch
Moderna Therapeutics, a US biotech firm, says it has received $1.1 customer deposits ahead of its global COVID-19 vaccine launch. The biotechnology company revealed this in its third quarter…